|Application ||WB, E|
|Other Accession||NP_001164174.1, NP_001164173.1, NP_597846.1, NP_001164175.1, NP_001164172.1, NP_060858.2|
|Calculated MW||38532 Da|
|Antigen Region||251-280 aa|
|Other Names||Muscleblind-like protein 3, Cys3His CCG1-required protein, Muscleblind-like X-linked protein, Protein HCHCR, MBNL3, CHCR, MBLX39, MBXL|
|Target/Specificity||This MBNL3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 251-280 amino acids from the Central region of human MBNL3.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||MBNL3 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Synonyms||CHCR, MBLX39, MBXL|
|Function||Mediates pre-mRNA alternative splicing regulation. Acts either as activator or repressor of splicing on specific pre-mRNA targets. Inhibits cardiac troponin-T (TNNT2) pre-mRNA exon inclusion but induces insulin receptor (IR) pre-mRNA exon inclusion in muscle. Antagonizes the alternative splicing activity pattern of CELF proteins. May play a role in myotonic dystrophy pathophysiology (DM). Could inhibit terminal muscle differentiation, acting at approximately the time of myogenin induction.|
|Cellular Location||Nucleus. Cytoplasm. Note=Greater concentration in the nucleus. In both DM1 and DM2 patients, colocalizes with nuclear foci of retained expanded-repeat transcripts|
|Tissue Location||Highly expressed in the placenta.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a member of the muscleblind-like family of proteins. The encoded protein may function in regulation of alternative splicing and may play a role in the pathophysiology of myotonic dystrophy. Alternatively spliced transcript variants have been described.
Holt, I., et al. Am. J. Pathol. 174(1):216-227(2009)
Self, J.E., et al. Mol. Vis. 12, 1211-1216 (2006) :
Ho, T.H., et al. EMBO J. 23(15):3103-3112(2004)
Squillace, R.M., et al. Dev. Biol. 250(1):218-230(2002)
Fardaei, M., et al. Hum. Mol. Genet. 11(7):805-814(2002)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.